Wei Zhao

Professor
The First Affiliated Hospital of Shandong First Medical University, Shandong, P.R. China
Taian, Tianjin, China (People's Republic)

Presentation(s):

• OC 21.5 - An Open-label,Dose-Escalation,Multicenter Phase I Study to Evaluate the Safety,Immunogenicity,and Pharmacokinetics/pharmacodynamics（PK/PD）of Single Dose SS109 in Hemophilia A/B patients with Inhibitor

  Sunday, June 23, 2024
  15:45 – 16:00 ICT